PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
10-Jun-2022 CordenPharma Increases xRNA-based Capabilities with a Strategic Investment in LNP Formulation Services at its Caponago Injectable Facility CordenPharma
10-Jun-2022 Coave Therapeutics and ABL enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy Coave Therapeutic
10-Jun-2022 Gilead and Kite Oncology to present latest blood cancer research at the European Hematology Association (EHA) 2022 Congress Gilead and Kite Oncology
10-Jun-2022 Anaveon Announces FDA Safe to proceed letter for Investigational New Drug (IND) Application for its no-alpha IL-2 agonist, ANV419 Anaveon
10-Jun-2022 NICE Recommends Astellas’ EVRENZO▼™ (roxadustat) For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease Astellas Pharma Ltd
10-Jun-2022 MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022 MorphoSys AG
10-Jun-2022 Envision Pharma Group partners with scite to display Smart Citations in iEnvision® – the global medical affairs platform Envision Pharma Group
10-Jun-2022 Kinarus Therapeutics Announces Name Change and Commences Trading on the SIX Swiss Exchange under ticker “KNRS” Kinarus AG
10-Jun-2022 Biotest AG: Biotest achieves important milestone in Phase III study in acquired fibrinogen deficiency Biotest AG
09-Jun-2022 PEPperPRINT GmbH Introduces Novel Biomarker Set for Rheumatoid Arthritis Diagnosis at the 13th International Congress on Autoimmunity B3C newswire
09-Jun-2022 Biotest AG: Biotest AG opens 11th plasma collection centre in Czech Republic Biotest AG
08-Jun-2022 CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform CureVac
08-Jun-2022 CureVac Announces Changes of CDO - Myriam Mendila to succeed Klaus Edvardsen CureVac
08-Jun-2022 Annual General Meeting of Kuros Biosciences approves all resolutions Kuros Biosciences AG
08-Jun-2022 Cellbox Solutions Releases Its New Product Generation - Cellbox 2.0 - Innovative Portable Incubator Now with Longer Runtime, CFR21/11 Clinical Trial Compatibility and More Cellbox Solutions
08-Jun-2022 Tiziana Life Sciences Announces Positive Clinical Results in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) Following Three Months of Dosing with Intranasal Foralumab Tiziana Life Sciences
08-Jun-2022 Gerresheimer AG: Annual General Meeting of Gerresheimer AG approves dividend of EUR 1.25 per share following a successful financial year – Gradual renewal of Supervisory Board initiated Gerresheimer AG
08-Jun-2022 Cellbox Solutions Releases Its New Product Generation - Cellbox 2.0 - Innovative Portable Incubator Now with Longer Runtime, CFR21/11 Clinical Trial Compatibility and More B3C newswire
08-Jun-2022 Malaria breakthrough. A collaboration between ISS, IRBM and CNR has led to the discovery of new molecules blocking the transmission of the parasite. Istituto Superiore di Sanità
08-Jun-2022 Parse Biosciences Announces Partnership with Molecular Diagnostics Korea Parse Biosciences